Similar articles

• [Clinical study of UFT in renal cell carcinoma].

  Masuda F, Suzuki M, Ohnishi T, Nakada J, Mori Y, Iizuka N, Machida T. Masuda F, et al. Gan To Kagaku Ryoho. 1985 Feb;12(2):325-30. Gan To Kagaku Ryoho. 1985. PMID: 3918508 Japanese.
• [Clinical effect of UFT in advanced renal cell carcinoma].

  Hoshino M, Inoue K, Higaki M, Imamura K. Hoshino M, et al. Hinyokika Kiyo. 1988 Mar;34(3):538-40. Hinyokika Kiyo. 1988. PMID: 3133935 Japanese.
• [Clinical study of UFT in far-advanced renal cell carcinoma].

  Matsuyama H, Yamamoto N, Sakatoku J, Hara Y, Sacho T, Yasui H, Ichikawa T, Koshido Y, Hayasida S, Nagata K, et al. Matsuyama H, et al. Gan To Kagaku Ryoho. 1988 Mar;15(3):527-30. Gan To Kagaku Ryoho. 1988. PMID: 3126711 Japanese. No abstract available.
• Treatment of recurrent or metastatic renal cell carcinoma.

  Shah RN, Ahmad T, Eisen TG. Shah RN, et al. Expert Rev Anticancer Ther. 2004 Dec;4(6):1069-80. doi: 10.1586/14737140.4.6.1069. Expert Rev Anticancer Ther. 2004. PMID: 15606334 Review.
• Metastatic renal cell carcinoma: systemic treatment.

  Abi-Aad AS, deKernion JB. Abi-Aad AS, et al. Acta Urol Belg. 1996 May;64(2):3-8. Acta Urol Belg. 1996. PMID: 8701805 Review. No abstract available.